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Abstract
Genital infection by high risk Human Papillomavirus (HR-HPV), although recognized as the main etio-pathogenetic factor of
cervical cancer, is not per se sufficient to induce tumour development. Oxidative stress (OS) represents an interesting and
under-explored candidate as a promoting factor in HPV-initiated carcinogenesis. To gain insight into the role of OS in
cervical cancer, HPV-16 positive tissues were collected from patients with invasive squamous cervical carcinoma, from
patients with High Grade dysplastic HPV lesions and from patients with no clinical evidence of HPV lesions. After virological
characterization, modulation of proteins involved in the redox status regulation was investigated. ERp57 and GST were
sharply elevated in dysplastic and neoplastic tissues. TrxR2 peaked in dysplastic samples while iNOS was progressively
reduced in dysplastic and neoplastic samples. By redox proteomic approach, five proteins were found to have increased
levels of carbonyls in dysplastic samples respect to controls namely: cytokeratin 6, actin, cornulin, retinal dehydrogenase
and GAPDH. In carcinoma samples the peptidyl-prolyl cis-trans isomerase A, ERp57, serpin B3, Annexin 2 and GAPDH were
found less oxidized than in dysplastic tissues. HPV16 neoplastic progression seems associated with increased oxidant
environment. In dysplastic tissues the oxidative modification of DNA and proteins involved in cell morphogenesis and
terminal differentiation may provide the conditions for the neoplastic progression. Conversely cancer tissues seem to attain
an improved control on oxidative damage as shown by the selective reduction of carbonyl adducts on key detoxifying/pro-
survival proteins.
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Introduction
Human Papillomavirus type 16 (HPV16) is the most prevalent
High Risk (HR) type in premalignant and malignant cervical
lesions [1]. The combined actions of its oncogenes E5, E6, E7
deregulate many cellular functions providing the conditions for
genetic damage accumulation and cancer progression [2].
Experimental and epidemiological evidences however indicate
that the vast majority of cervical infections regress spontaneously
while only a minor part of them eventually progresses to invasive
cancer. Thus HPV infection, although necessary, is not per se
sufficient to induce cancer. Other factors have to be involved in
the progression of infected cells to the full neoplastic phenotype.
The present poor knowledge about the neoplastic progression
mechanisms has dramatic consequences on the clinical side. As a
matter of fact based on the current screening methods, it is not
possible to predict the clinical outcome of a single lesion. Thus
while just a very minor part of them tend to progress all of them
have to be regarded as a potentially progressive. Consequently a
large number of patients have to be treated as potentially
progressive patients and are therefore submitted to ultimately
unnecessary surgical treatments. In the search for molecular
markers able to predict the clinical outcome of dysplastic lesions
many of viral, host-related and environmental factors have been
taken into account and examined. Nevertheless HPV related
carcinogenesis remains poorly understood and current screening
protocols still wait improvements. Among environmental factors
Oxidative Stress (OS), although appearing a good candidate as
cancer promoting factor has been comparatively neglected so far.
OS is a condition arising when the production of reactive oxygen
species (ROS) is not matched by the antioxidant/repairing
pathways of the cell. ROS are constantly generated in aerobic
cells by the incomplete reduction of molecular O2 to H2O during
mitochondrial oxidative phosphorylation, as well as during a
number of processes such as inflammation, infections, mechanical
and chemical stresses, exposure to UV and to ionising irradiation
[3,4]. ROS cause oxidative damage to cell membrane lipids,
proteins, and nucleic acids having the potential to induce both
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acute and chronic degenerative processes including ageing and
cancer [5,6]. This work aims to identify new molecular markers
correlating with neoplastic progression in HPV 16 transformed
cervical cells. To this purpose the expression of OS related
proteins and the pattern of oxidative adducts on cell proteome (the
redox proteome) were assessed on cervical tissues of patients with
HPV 16 infection. Overall, our results indicated that an increased
oxidant environment is associated with an increased antioxidant
activity in dysplastic and neoplastic tissues. Their potential role in
cancer progression is discussed.
Materials and Methods
Patients enrolment
The study design and enrolment criteria were approved by the
Regina Elena’s local Ethical Committee. All participants provided
full written informed consent [7]. Patients attending either the
Gynecological Department of the Regina Elena Cancer Institute
of Rome (Italy) or the Oncological Hospital at the University
Hospital center ‘‘Mother Teresa’’ of Tirana (Albania) and
presenting with clinically/colposcopic evidence of dysplastic
lesions or invasive cervical cancer, were invited to participate to
the study. Women with evidence of uterine fibroleiomyoma were
also invited to participate as ‘‘non neoplastic controls’’. Eligibility
criteria: to be eligible patients had to be at least 18 years old, to be
not pregnant, not suffering form any other disease apart the reason
for asking gynecological advise, to have no/to have never suffered
from other neoplastic disease. During the period, January 2008 to
December 2009, 87 women were selected among those providing
a full written informed consent and matching the above inclusion
criteria. At entry, enrolled patients underwent a full gynecological
examination. Ecto-cervical cells were collected and stored in Thin-
Prep for liquid based cytology and virological assays. Histological
samples were taken and divided into two halves. One used for
standard histo-pathological evaluation and processed under
current criteria. The second one was immediately frozen in dry
ice/ethanol bath and used later for viral assay and for protein
extraction. Any decision about patients’ diagnosis, treatment and
follow-up, was based merely on current clinical criteria irrespective
of any research need.
Protein extraction
Fresh or frozen histological samples were cut in small pieces and
incubated for 20 min in ice with lysis buffer (10 mM Hepes
pH 7.9, 10 mM K2EDTA, 5 mM NaCl, 1% TritonX-100,
10 mM â-mercapto-ethanol, aprotinine 5 mg/L). Lysates were
sequentially disrupted by a mechanical mincer (Ultra-Turrax IKA
T10) and by a potter device, until a fine, cloudy suspension was
obtained. The suspension was then clarified in a JA-21 Beckman
Super-centrifuge at 16,000 g for 20 min at +4uC. Protein
concentration in the supernatant was determined by the
Coomassie Plus Pierce Protein Assay (Pierce Inc., Rockford, IL,
USA). Samples were then divided into aliquots and stored at
280uC until use.
Viral analyses
DNA was extracted from a small piece of tissue by the QIAamp
DNA Mini Kit (QIAGEN Gmbh, Hilden, Germany) used
according to the manufacturer’s instructions.
For HPV detection the samples were amplified using the
MY09/MY11 primer couple [8]. Samples adequacy to PCR
analysis was assessed by a parallel b-globin gene amplification with
primers GH-20/PC-04 (tab. 1) as described by Saiki et al, 1988
[9]. In both cases amplification consisted in an initial step at 95uC
for 150 sec for Polymerase activation, followed by 35 cycles of
denaturation at 95uC for 30 sec, annealing at 56uC for 30 sec and
of extension at 72uC for 40 sec plus a final cycle with a 10 min
long extension for optimal chain termination. Amplified products
were separated by 2.5% Etidium bromide stained agarose gel
electrophoresis and visualized under UV-B trans-illumination by
gel direct inspection. The HPV-16 positive Siha, CaSki and HK-
168 [10] cell lines were used as positive controls. HaCaT cells were
used as negative controls.
Viral typing was assessed by direct sequencing of amplified
products by the BigDye Terminator 1.1 Cycle Sequencing Kit
(Sanger method). Sequences were aligned to prototype viral
sequence through the BLAST resource at the NCBI(http://www.
ncbi.nlm.nih.gov).
The viral load of HPV-16 positive samples was determined by a
SYBR Green quantitative PCR (qPCR) procedure based on the
work of Roberts et al. [11] with minor modifications. Briefly total
DNA was extracted and purified from 107 Siha cells and adjusted
to 1.0 ml final volume in Tris EDTA Buffer pH 8.0. Tenfold serial
dilution were derived from the above stock solution producing a
titration series of 104, 103, 102, 101, 100 cell genome/ml and used
to derive target-specific standard curves in every PCR session.
With its 1:1 ratio for the E6:b-globin genes this line provides an
excellent reference for the simultaneous assessment in complex
clinical samples of both viral copies and cellular abundance. All
PCR were carried out in a IQ4 Biorad Cycler with Iq SYBR
Green Supermix (both purchased from Biorad Srl, MI, Italy).
Reactions were set up in 25 ml final volume containing 16
reaction mixture, 500 nM of each primer and 1 ml of standard or
sample DNA. Amplification conditions consisted in: TaQ
polymerase thermal activation at 95uC for 150 sec followed by
35 cycles of denaturation at 95uC for 30 sec; annealing at 56uC for
30 sec; extension at 72uC for 40 sec; sample reading at 75uC for
10 sec. A final cycle extension at 72uC for 10 min followed by a
melting curve ranging from 70uC to 95uC with 0,5uC incremental
temperature/10 second step were incorporated. The copy number
of the viral oncogenes E6 (table 1) and the cell number (i.e: the
number of human b globin copies) in experimental samples were
evaluated referring the amplicon threshold cycle (assayed in
duplicate) to its specific standard curve (assayed in triplicate). The
primers used are listed in table 1. The average lesional Viral Load
was then calculated as the E6/beta globin ratio and expressed as
viral Copies per Haploid Cellular Genome (CHCG).
To obtain information about the physical status of viral genome
the Rolling Circle Amplification (RCA) was used [12,13]. Such a
recently implemented procedure specifically dedicated to the
positive detection of episomal genomes was performed with the
TempliPhi 100 Amplification Kit (Amersham Biosciences UK
Limited, Amersham, UK) used according to the manufacturer’s
instructions.
Western blot
Endoplasmic Reticulum protein 57 (ERp-57), glutathione S-
transferase (GST), inducible nitric oxide synthase (i-NOS) and
thioredoxin reductase 2 (TrxR2) levels were evaluated by Western
blot analyses. Sample aliquots (40 mg of protein) were subjected to
12.5% SDS-PAGE and electroblotted (1 h at 100 V) to nitrocel-
lulose membranes (Bio-Rad) using 25 mM Tris, 192 mM glycine
and 20% (v/v) methanol. Equal protein loading was confirmed by
staining with 0.2% v/v Ponceau S in 7% acetic acid. Blotted
membranes were blocked with 3% albumin in T-TBS and
challenged with appropriate primary antibodies, namely anti-Erp-
57 rabbit polyclonal antibody, anti-GST mouse monoclonal
antibody, anti-iNOS rabbit polyclonal antibody (Upstate, Milli-
Redox Proteomics in Cervical Cancer
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pore S.p.a, MI, IT) and TrxR2 goat polyclonal antibody (Santa
Cruz Biotech. Inc., Santa Cruz, CA,USA) for 1 h at room
temperature. Unbound antibodies were removed by washing twice
with Tris-buffered saline containing 0.1% Tween 20, for
5 minutes. The membranes were then incubated with horseradish
peroxidase-conjugated secondary antibody (Sigma–Aldrich Inc.
St. Louis, MO) diluted 1:5000. Protein bands were visualized with
ECL PlusTM (Amersham) according to the manufacturer’s
protocol. Blots were scanned on a GS880 densitometer (Biorad)
and quantified by QuantityOne image software.
Protein oxidation measurement
Protein oxidation was measured according to Butterfield et al.
[14]. Briefly, samples (5 mL) were added with 5 mL of 12% SDS
and derivatized with 10 mM 2,4-dinitrophenylidrazine (DNPH) at
room temperature for 20 min. Samples were neutralized with
7.5 mL of neutralization solution (2 M Tris in 30% glycerol).
Derivatized samples (250 ng) were then blotted onto a nitrocel-
lulose membrane under vacuum using a slot-blot apparatus (Bio-
Rad). Membranes were blocked with 3% BSA in TBS-T for 1 h
and next incubated with rabbit antibody to protein-bound DNP
(diluted 1:150) for 90 min. After washing with TBS-T, membranes
were incubated with anti-rabbit IgG alkaline phosphatase
secondary antibody (1:5000) in TBS-T for 1 h at room
temperature. The membrane was washed in TBS-T and
developed using a solution of NBT (0.2 mM) and BCIP
(0.4 mM) in alkaline phosphate buffer (0.1 M Tris, 0.1 M NaCl,
5 mM MgCl2; pH 9.5). Dried blots were quantified using
QuantityOne image analysis (Bio-Rad).
2D electrophoresis and western blot
For the first-dimension electrophoresis, proteins (200 mg in
200 mL of rehydration buffer) were applied to a ReadyStripTM
IPG strip pH 3–10 (Bio-Rad). The strips were soaked in the
sample solution for 1 h to allow uptake of the proteins. The strips
were then actively rehydrated in Protean IEF Cell Apparatus (Bio-
Rad) for 16 h at 50 V. The isoelectric focusing was performed at
300 V for 2 h linearly; 500 V for 2 h linearly; 1000 V for 2 h
linearly, 8000 V for 8 h linearly and 8000 V for 10 h rapidly. All
the processes above were carried out at room temperature. The
focused IEF strips were stored at 280uC until second dimension
electrophoresis was performed.
For second dimension electrophoresis, thawed strips were
equilibrated for 10 min in 50 mM Tris-HCl (pH 6.8) containing
6 M urea, 1% (w/v) sodium dodecyl sulfate (SDS), 30% (v/v)
glycerol, and 0.5% dithiothreitol, and then re-equilibrated for
15 min in the same buffer containing 4.5% iodacetamide in place
of dithiothreitol. 12% Precast criterion gels (Bio-Rad) were used to
perform second dimension electrophoresis. Precision ProteinTM
Standards (Bio-Rad) were run along with the sample at 200 V for
65 min. After electrophoresis, the gels were fixed (7% acetic acid,
10% methanol) and stained with Bio-Safe Coomassie Gel Stain
(Bio-Rad).
To identify carbonylated proteins, samples (200 mg proteins)
were derivatized as above described, subjected to 2-DE and
transferred to nitrocellulose membrane using Criterion Blotter
apparatus (Bio-Rad) at 100 V for 1 h. The carbonylated proteins
were detected as above reported.
Image Analysis
The 20 gels (n = 7 controls, n = 6 dysplasia and n = 7 carcinoma)
and 20 nitrocellulose blots were scanned and saved in TIF format
using a GS-800 densitometer (Bio-Rad). PDQuest 2D Analysis
software (version 7.2.0, Bio-Rad) was used for matching and
analysis of visualized protein spots among differential gels and
membranes. The anti-DNP immune-reactivity of individual
proteins was normalized to protein content evaluated by the
intensity of Coomassie blue stained spots. After completion of spot
matching, the normalized intensity of each protein spot from
individual gels was compared among the groups using statistical
analysis. Statistical significance was assessed by a two-tailed
Student’s t-test, the method of statistical analysis most appropriate
for proteomic analysis of small number of protein spots [15]. P
values ,0.05 were considered significant for comparison between
control and experimental data.
Trypsin digestion and protein identification by mass
spectrometry
Selected spots were manually excised from gel and submitted to
trypsin proteolysis [16]. MALDI-ToF MS analyses were per-
formed in a Voyager-DE STR instrument (Applied Biosystems,
Framingham, MA, USA) equipped with a 337 nm nitrogen laser
and operating in reflector mode. Mass data were obtained by
accumulating several spectra from laser shots with an accelerating
voltage of 20 kV. Two tryptic autolytic peptides were used for the
internal calibration (m/z 842.5100 and 2807.3145). Data were
analysed by MoverZ program (v. 2002, http://bioinformatics.
Table 1. Sequence, Tm and references of primers used.
PRIMERS 59-39 SEQUENCES Bp Tm(C6) reference
MY09 CGTCCMARRGGAVVACTGATC ,450 50 Manos et al 1989
MY11 GCMCAGGGVVCATAAYAATGG 52
GH20 GAAGAGCCAAGGACAGGTAC 260 62 Saiki et al 1988
PC04 CAACTTCATCCACGTTCA CC 60
16E6-S 26 AAGGGCGTAACCGAAATCGGT 207 64 Nagao et al 2002
16E6-AS 233 CATATACCTCACGTCGCAG 58
16E2-S 3383 TTATTAGGCAGCACTTGGCCA 177 62 Nagao et al 2002
16E2-AS 3560 GTGAGGATTGGAGCACTGTCC 64
16E2-S 2734 AGGACGAGGACAAGGAAAA 1139 56 Yoshinouchi et al 1999
16E2-AS 3846 GGA TGC AGT ATC AAG ATT TG 56
Names of HPV16 primers include sense of primer extension followed by the position of the 59 nt on prototype sequence for rapid primer location.
doi:10.1371/journal.pone.0034366.t001
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Table 2. List of HPV-16 positive patients together with their major clinical, virological and pathological determinants.
ID Age
DNA
viral load RCA Cytology Kolposcopy Histology
Stage
(FIGO)
Hist
Grade
Lymph
Node Met
Distant
Met
Z A 51 3,1761023 ND Normal ND Negative - - - -
E L 44 3,0061024 ND Normal ND Negative - – – -
V M 32 2,1961022 ND Normal ND Negative - - - -
Q M 50 3,5061022 Positive Normal ND Negative - - - -
H C 55 1,9861023 ND Normal ND Negative - - - -
H S 51 2,3061023 ND Normal ND Negative - - - -
B Z 51 3,1161023 ND Normal ND Negative - - - -
D H 48 1,5261022 ND HSIL ANTZ G1 CIN-II - - - -
E M 35 7,6061023 ND HSIL ANTZ G2 CIN-III - - - -
M B 40 3,3061023 ND HSIL ANTZ G2 CIN-III - - - -
M T 31 9,261023 ND HSIL ANTZ G2 CIN-II - - - -
L B 43 6,6861022 ND HSIL ANTZ G1 CIN-III - - - -
T S 39 4,2761023 ND HSIL ANTZ G2 CIN-III - - - -
M R 55 1,16102 Positive HSIL/worse ANTZ G2 Invasive SCC IIA G3 No No
D A 48 5,606101 Positive HSIL/worse ANTZ G2 Invasive SCC IIB G3 No No
M S 64 2,006101 ND HSIL/worse ANTZ G1 Invasive SCC IB1 G2 No No
C G 44 1,816101 ND HSIL/worse ANTZ G2 Invasive SCC IIB G3 No No
D9A A 68 9,2061024 ND HSIL/worse ANTZ G1 Invasive SCC, with
basaloid aspects
IIA G2 No No
G I 40 5,886100 ND HSIL/worse ANTZ G2 Invasive EC IIB G3 No No
N B 59 3,006102 ND HSIL/worse ANTZ G2 Invasive SCC, IIB G3 No No
F R 52 6,2361021 ND HSIL/worse ANTZ G2 Invasive EC IIB G3 Yes No
S C 47 2,356102 ND HSIL/worse ANTZ G2 Invasive SCC, IIB G3 No No
A M 43 1,226101 ND HSIL/worse ANTZ G2 Invasive SCC, IA1 G3 No No
P B 45 3,006100 ND HSIL/worse ANTZ G2 Invasive SCC, IIA G2 No No
C C 46 4,606102 ND HSIL/worse ANTZ G2 Invasive SCC, IIA G3 No No
A M 52 6,506102 ND HSIL/worse ANTZ G2 Invasive SCC, IIB G2 No No
P MC 55 5,46101 ND HSIL/worse ANTZ G2 Invasive SCC, IIA G3 No No
G.R 73 3,6061023 ND HSIL/worse ANTZ G2 Invasive EC IIA G2 Yes No
A.LE 70 7,806100 ND HSIL/worse ANTZ G2 Invasive SCC, IB2 G3 No No
M P 58 1,256103 ND HSIL/worse ANTZ G2 Invasive SCC IB2 G2 No No
M M 75 7,3061022 ND HSIL/worse ANTZ G1 Invasive SCC, IB2 G2 No No
P E 53 1,76100 ND HSIL/worse ANTZ G2 Invasive SCC, IIB G3 No No
M M 56 7,436102 ND HSIL/worse ANTZ G2 Invasive EC IB2 G2 No No
V A 49 4,9161022 ND HSIL/worse ANTZ G2 Invasive SCC, IIA G3 Yes No
M GM 51 6,906101 ND HSIL/worse ANTZ G2 Invasive SCC, IIB G2 Yes No
D9A L 47 1,361021 ND HSIL/worse ANTZ G2 Invasive SCC, IIA G3 No No
T E 59 8,36102 ND HSIL/worse ANTZ G2 Invasive SCC, IA2 G3 No No
M R 56 7,706100 ND HSIL/worse ANTZ G2 Invasive SCC, IB1 G2 No No
HK-168 - 2.86100 ND ND - HPV-16 in vitro
transformed human
keratinocytes
- - - -
SiHa - 1.096100 ND ND - Invasive SCC cell line - - - -
Caski - 6556102 ND ND - Invasive SCC cell line - - - -
HaCaT - ND ND ND - Spontaneously
Immortalized human
keratinocytes cell line
- - - -
ID: patient’s identification code; DNA viral load was calculated as the E6/beta globin ratio and expressed in copy per haploid cellular genome CHCG; HSIL: High grade
Squamous Intraepithelial Lesion; ANTZ: Abnormal Transformation Zone; Histological Grade: G1 Well differentiated; G2 Moderately differentiated; G3 Poorly
differentiated. Met: metastases. ND: none detected; SCC samples selected for redox-proteomics analysis are boxed.
doi:10.1371/journal.pone.0034366.t002
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genomicsolutions.com), according to default parameters. Identifi-
cation by peptide mass fingerprint (PMF), with the mono-isotopic
mass list, after exclusion of expected contaminant mass values by
Peak Erazor program (http://www.protein.sdu.dk/gpmaw/Help/
PeakErazor/peakerazor.html), was performed using the Mascot
search engine (v. 2.3) against human SwissProt database [(Swis-
sProt 2011_08 (531473 sequences; 188463640 residues)]. Up to
one missed cleavage, 50 ppm measurement tolerance, oxidation at
methionine (variable modification) and carbamidomethylation at
cysteine (fixed modification) were considered. Identifications were
validated when the probability-based Mowse protein score was
significant according to Mascot [17].
GAPDH activity assay
GAPDH activity was measured by a colorimetric assay kit
(ScienCell, Research Laboratories Co, Carlsbad, CA). The
method is based on the oxidization of â-NADH to â-NAD in
the presence of 3-phosphoglyceric acid (3-PGA), adenosine 59-
triphosphate (ATP) and GAPDH. The GAPDH activity is
determined by assaying the rate of NADH oxidation, which is
proportional to the reduction in absorbance at 340 nm over time
(A340 nm/min). Briefly, 5 ml of each sample or standard is added to
each well, in the 96-well plate, containing 145 ml of GAPDH assay
mixture, and the A340 nm kinetic was measured. Enzyme activity is
calculated as U.A./mg protein.
Determination of 8-hydroxy-2-deoxy Guanosine (8-OH-
dG). DNA oxidation was evaluated by the 8-OH-2deoxy
Guanosine EIA kit (StressMarq Biosciences Inc, Victoria BC
CANADA) used according to the manufacturer’s instructions.
Chemicals and biochemical
All other materials used unless otherwise specified were
analytical grade products purchased from the current laboratory
suppliers either Sigma–Aldrich (St. Louis, MO, USA) or Bio-Rad
(Bio-Rad Laboratories, Milan, Italy).
Statistical analysis
Two-sided, Student’s t-tests were used to analyze differences in
protein levels between dysplasia and carcinoma. A p-value of less
than 0.05 was considered statistically significant. The significance
of the change in carbonylation of specific proteins in the
proteomics study was evaluated via nonparametric Mann-
Whitney-Wilcoxon test. P ,0.05 was considered statistically
significant.
Results
Patients
During the period from January 2008 to December 2009 a total
of 87 patients yielded their consent to participate to the study.
Among them 35 had an invasive squamous cell carcinoma (SCC),
1 an adeno-carcinoma, 12 were affected by a cervical dysplastic
lesion and 23 were suffering for a uterine fibroleiomyoma. The
remaining 15 patients turned out to be affected by other
inflammatory or chronic/degenerative pelvic diseases and were
excluded from further analyses. Viral typing showed that HPV16
was present in 25/35 patients with invasive SCC, in 6/12 patients
with dysplastic lesion and in 7/23 patients with uterine
fibroleiomyoma. These latter, for the sole purpose of this work
are here considered as control patients. All the HPV16 patients,
listed in table 2 entered the study and were further characterized.
The major clinical features concerning tumour staging and
grading are also reported together with viral determinats.
Viral load and viral genome physical status
Viral load and viral genome physical status have been claimed
to be relevant determinants in HPV infection outcome and in
clinical evaluation of dysplastic and neoplastic lesions. Various
methodologies are described for the evaluation of viral load. We
worked with the SYBR Green method following the recommen-
dation of Roberts et al. [11] with modifications. The E6 and the
humanbeta globin gene quantification was based on a standard
curve generated by a logarithmic dilution series of Siha cells, a cell
line known to host a single, integrated, almost complete HPV16
CHCG [11,18]. Primers with close annealing temperature and
generating amplicons of similar length were chosen to keep to a
minimum the bias due to differential target amplification (table 1).
The HPV-16 E6 primers encompassed the region from nucleotide
(nt) 26 to nt 233 generating a 207 bp long amplicon [19]. The
primers for beta-globin (GH-20 and PC04) spanned the start
codon of the human beta-globin amplifying a 268 bp tract. The
viral load obtained for each specimen are listed in table 2 and
plotted in figure 1. As it can be seen, in control tissue (i.e.: cervical
tissue devoid of clinically evident dysplastic lesion) a mean viral
load of 0.9661022 CHCG was found. All but one single value
clustered close to the mean value and all of them were clearly
below the 1021 CHCG level. A very similar finding was obtained
for dysplastic samples with a mean viral load of 2.2061022
CHCG and much less scattered values. Conversely a sharply
higher mean value of 1.656102 viral CHCG was observed among
invasive cancer although values were widely dispersed across seven
orders of magnitude (from 1024 up to 103 CHCG). The HK-168,
Siha and CaSki cell lines, here used as low and high ratio positive
control consistently yielded the expected values of around 100; 100
and 102–103 viral CHCG respectively.
The physical status of viral genomes in the samples is reported
in table 2. As it can be seen, with the RCA method, a method
specifically dedicated to the direct detection of circular DNAs,
episomal forms were positively identified just in one normal
sample and in two neoplastic ones.
Expression levels of stress response proteins
Expression levels of selected stress response proteins, including
Endoplasmic Reticulum protein 57 (ERp57), Glutathione S-
Transferase (GST), inducible Nitric Oxide Synthase (iNOS) and
mitochondrial Thioredoxin Reductase (TrxR2) were evaluated in
control, dysplastic and neoplastic tissues (figure 2).
Figure 1. Viral load. Viral loads in CTR, DYS and SCC cervical tissues
are expressed as E6 copies/b-globin copies/cell.
doi:10.1371/journal.pone.0034366.g001
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Erp57 is an ER stress marker and our previous work showed
that it is a selective target of OS in epithelial cells [20]. In
neoplastic tissues the expression level of ERp57 was significantly
increased compared with both dysplastic and control tissues
(figure 2, panel A).
GST is a detoxifying enzymes found to be overexpressed in
different tumors, though no data are available in cervical cancer.
Further, growing studies proposed that GST polymorphism is a
candidate risk factor for developing cervical cancer. GST was
sharply increased in dysplastic and in neoplastic cells compared
with controls (up to 1.8 and 6 fold respectively) (figure 2, panel B).
The TrxR2, participates in mitochondrial redox signaling
events and it has been recently regarded as a cancer development
[21].The TrxR2, as compared with control tissue, was significantly
increased in dysplastic lesions and, to a lower extent, in neoplastic
lesions too (175% and 125% respectively).
i-NOS, the inducible isoform of Nitric Oxide Synthase, is a well-
established marker of nitrosative stress and inflammation. Its
specific role in tumor biology is still under debate. iNOS was found
to be progressively decreased in dysplastic (65% of control) or
neoplastic (25% of control) samples as compared with control
tissues (figure 2, panel D).
Protein oxidation
To assess the extent of total protein oxidation, protein carbonyl
levels were evaluated by slot-blot analysis (figure 3). Protein
carbonyls were significantly increased in dysplastic tissues respect
to control samples, while the levels detected in neoplastic tissues
were surprisingly similar to control ones.
Identification of carbonylated proteins
For the redox proteomics analysis, a set of 7 SCC samples were
selected from those reported in table 2, to be compared, with the 6
dysplastic tissues and the 7 control ones.
Two representative 2D gels, and the corresponding blots,
from control and dysplastic samples are pictured in figure 4 and
Figure 2. Expression levels of stress markers (ERp57, GST, TRX-R2 and iNOS). Protein expression levels in CTR, DYS and SCC cervical tissues
were measured by Western blot analysis using specific antibodies for ERp57 (A), GST (B), TRX-R2 (C) and iNOS (D). Immunoblots were scanned by
densitometry and all values were normalized to b-actin levels. Densitometric values shown are given as percentage of the control group, set as 100%.
Data are expressed as mean 6 SEM. p,0.05 versus control (Student’s t-test).
doi:10.1371/journal.pone.0034366.g002
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5. MS identification of proteins, along with the peptide hits,
sequence coverage, Mw and pI values and the increase of
specific carbonyl levels, indexed as fold oxidation compared with
controls, are reported in table 3. 5 proteins were found to be
more oxidized in dysplastic tissues compared with controls,
namely in cytoskeletal Keratin 6 (CK 6, fragments/isoforms A,B
& C), Cornulin, Actin, GAPDH and Retinal Dehydrogenase
(RDH) (figure 4). These are proteins involved in cytoskeleton
scaffolding (keratins and actins) and epidermal differentiation
(cornulin, RDH).
Two proteins were identified in the same spot: the fragments/
isoforms A,B & C of cytoskeletal Keratin 6 (with a score of 327,
283 and 311 respectively) and the pyruvate kinase with a score of
66 (around the threshold limit).
Figure 3. Total protein oxidation. Top: Quantification of levels of protein carbonyls in CTR, DYS and SCC cervical tissues. Samples were probed
with anti-DNP protein adducts polyclonal antibody as described in Material and Methods. Densitometric values shown are given as percentage of the
control group, set as 100%. Data are expressed as mean 6 SEM. p,0.05 versus control (Student’s t-test). Bottom: Protein carbonyl slot- blots from
CTR, DYS and SCC samples.
doi:10.1371/journal.pone.0034366.g003
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Redox proteomics analysis was also performed to compare
dysplastic and neoplastic samples. Results indicated that five
proteins, namely Serpin B3, Annexin 2 (Anx2), ERp57 and
peptidyl-prolyl cis/trans isomerase (Pin1) and GAPDH were less
oxidized in neoplastic samples compared with dysplastic ones
(figure 5). Surprisingly, oxidized proteins did not show any
significant elevation in SCC tissues compared with controls.
Table 3 shows the proteins successfully identified by mass
spectrometry along with the peptide hits, sequence coverage, Mw
and pI values and the increase/decrease of specific carbonyl levels,
indexed as fold oxidation.
GAPDH activity. In order to see the effect of oxidative
modification on protein function, the enzymatic activity of
GAPDH has been measured in dysplastic and neoplastic tissues
compared with healthy controls. We found that dysplastic tissue
had a lower enzymatic activity compared with controls
(normalized to protein expression levels) while a recovery of
the activity was evidenced in SCC samples (Table 4). These data
result from the combined modification of both protein
expression levels and protein oxidation and confirms that
increased GAPDH carbonylation leads to impaired protein
function.
8-OH-dG. In order to support data on protein oxidation with
results obtained from alternative approaches the extent of DNA
oxidation was assessed by the levels of 8-OH-dG. This is an
established marker of DNA oxidative damage in response to
increased OS and ROS production. As it can be seen in Table 5,
dysplastic tissue showed elevated level of 8-OH-dG whereas
neoplastic samples displayed a surprising diminished levels as
compared with both controls and dysplastic tissues.
Discussion
Aiming to identify new candidate markers able to predict the
clinical outcome of lesions it was necessary to compare lesions with
highly homogeneous clinical and biological features. Thus
considering that viral load and viral genome physical status have
been assumed to be most relevant determinants in cervical
infection outcome [18,22,23], samples were carefully evaluated
under these two aspects. As above reported in normal samples, as
well as in dysplastic samples, a mean viral load of roughly 1022
CHCG was found while the sharply higher viral load of 1,656102
CHCG was revealed in SCC samples. These data are in
agreement with the cut off value recently proposed by Carcopino
et al. [24] for HPV-16 progressive lesions and indicate that the
groups of lesions were highly homogeneous and well distinct from
each other. Moreover, the physical status of viral genome is
consistent with data reported by other authors showing that viral
integration is not a stringent requisite for neoplastic growth, which
frequently occurs in cells hosting episomal viral genomes [25].
Remarkable differences were shown in stress response markers
among the three groups of lesions. The ERp57 was found to be
significantly up-regulated only in neoplastic tissue compared with
both dysplastic and controls tissues. The ERp57 is a ER resident
member of the protein-disulphide isomerase family, which assists
the maturation and transport of unfolded secretory proteins by
facilitating disulphide bond formation and rearrangement reac-
tions. ERp57 expression is induced during neoplastic transforma-
tion [26] possibly leading to redox-dependent modulation of
cancer relevant regulatory factors [27,28]. GST expression was
found to be induced in dysplastic tissues and even more in
Figure 4. Oxidized protein detection by redox proteomics (DYS vs. CTR). Top: 2D maps of CTR (left) and DYS (right) cervical tissues. Proteins
(300 mg) were separated in first dimension (pH 3–10 linear IPG); second dimension was performed on slab gel (12% gradient SDS-PAGE). Protein
detection was achieved using Biosafe Coomassie staining. Bottom: 2D carbonyl immunoblots of CTR (left) and DYS (right) cervical tissues. The spots
showing significant increased carbonyl levels are labeled. Relative change in carbonyl immune-reactivity, after normalization of the immunostaining
intensities to the protein content, was significant for five spots. The identified proteins are listed in table III.
doi:10.1371/journal.pone.0034366.g004
Redox Proteomics in Cervical Cancer
PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e34366
neoplastic tissues. Considering that various classes of GST iso-
enzymes are overexpressed in human tumour cell lines of different
histological origin [29] it is likely that such an elevation represents
an adaptive response mechanism, devoted to the detoxification of
oxidative stress related harmful metabolites.
The TrxR2 is part of an important mechanism for maintaining
the reduced intracellular environment. In addition to its possible
implication in many aspects of cancer biology [30] its specific role
in protein oxidative damage repair indicate that TrxR2 induction
represents an adaptive response against a condition of increased
ROS generation as it may occur during cancer growth [31].
The inducible form of NOS has been commonly associated with
malignant diseases, however its role in carcinogenesis and tumor
biology is far from being clarified. Our results indicated that
compared with the level found in control tissues, iNOS expression
was gradually reduced in dysplastic and neoplastic lesions. Though
divergent from what observed in most cancer types, this finding is
an agreement with the results by Mazibrada et al. [32] reporting
that iNOS expression was significantly reduced from low to high-
grade cervical lesions.
Taken together the above data support the view that highly
active detoxifying systems (ERp57; TrxR2; GST) and reduced
iNOS might be part of a complex adaptive metabolic profile
allowing cell survival in an increasingly oxidant environment.
In order to better understand the role of OS in cervical cancer,
we measured the extent of total protein oxidation. We found that
protein carbonyls were significantly increased in dysplastic tissues,
while levels detected in neoplastic tissues were not significantly
different to control ones. This unexpected trend was also
paralleled by the extent of oxidative DNA damage. Indeed we
found that 8-OH–dG levels were clearly increased respect to both
SCC and controls. These findings support the view that dysplastic
state is highly vulnerable to oxidative damage, a major factor of
genetic instability, providing the conditions for the neoplastic
evolution of transformed cells. Conversely established tumours
seem to fit well with stress conditions.
Since it has been demonstrated that protein oxidation results in
diminished, complete loss of, or a toxic gain in protein function
[33], the identification of specific proteins, which are irreversibly
modified by carbonylation, could shed light on the molecular
mechanism targeted by OS in cell transformation and tumor
development. By redox proteomics analysis, in dysplastic tissue
compared with controls five proteins were identified with
increased carbonylation levels, namely CK6, actin, cornulin,
RDH and GAPDH.
Cytokeratins (CKs) contribute to cytoskeleton organization and
are well known markers of cell differentiation both in normal and
neoplastic epithelia [34]. Their interaction with HPV transforming
activity has been reported [35] and their quantitative detection has
been proposed as an adjunct to current histological evaluation
[36]. Recently, Arnouk et al. reported a decreased expression of
CK6A and other CKs in HSIL and cervical cancer [37]. Our
results indicate that in addition to the altered pattern of expression
of CKs, a further level of cytoskeleton derangement seems to occur
in dysplastic lesion in consequence of the oxidative alteration of
CK6. Such a deregulation is potentially reinforced by the parallel
increased oxidation of actin which cooperates with CKs in
structural and functional cell shaping [38–39].
Cornulin is a calcium binding protein member of the fused-gene
family [40] normally expressed in late epidermal differentiation
Figure 5. Oxidized protein detection by redox proteomics (DYS vs. SCC). Top: 2D gel maps of DYS (right) and SCC (left) cervical tissues.
Protein (300 mg) were separated in first dimension (pH 3–10 linear IPG); second dimension was performed on slab gel (12% gradient SDS-PAGE).
Protein detection was achieved using Biosafe Coomassie staining. Bottom: 2D carbonyl immunoblots of DYS (right) and SCC (left) cervical tissues. The
spots showing significant increased carbonyl levels are labeled. Relative change in carbonyl immune-reactivity, after normalization of the
immunostaining intensities to the protein content, was significant for five spots. The identified proteins are listed in table III.
doi:10.1371/journal.pone.0034366.g005
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and currently used as a marker of differentiation [41]. Recently
cornulin has been reported to be severely reduced in cervical
dysplastic lesions and to be almost completely suppressed in
neoplastic lesions [37]. Our results show that in dysplastic lesion its
residual amount is likely to be further impaired due to its increased
level of oxidation, This result is consistent with the hypothesis,
proposed by Arnouk et al. [37] that cornulin is a promising
candidate marker that correlates with the neoplastic progression.
The RDH is an enzyme involved in the synthesis of retinoic
acid, a fundamental regulator of cell differentiation, embryo-
genesis, tissue homeostasis and renewal [42]. Several studies
reported retinoid implications in HPV related neoplastic
diseases including suppressive control on integrated E6 & E7
oncogenes [43,44]. The increased oxidation of RDH suggests its
altered/reduced activity in dysplastic lesion with possible
decreased control on cell differentiation maintenance as well
as on pro-survival and anti-apoptotic activity of integrated viral
oncogenes.
Taken together the above data indicate that in dysplastic lesions
a selective oxidation of CK6, Actin, Cornulin and RDH, concur to
impair their functions contributing to cytoskeleton derangement,
suppression of terminal differentiation and reduced control on
viral oncogenes activity.
Comparative analysis between SCC and CTR tissues did not
reveal any significant increase of carbonylated protein. This result
is consistent with total protein oxidation levels. However, further
larger studies are needed to clarify such an apparent enigma.
Comparing the redox proteomics pattern of dysplastic and
neoplastic tissues a number of proteins exhibited a lower oxidation
in neoplastic tissues namely the ERp57; Anx2; Serpin B3; Pin1
and GAPDH.
Table 3. List of oxidized proteins successfully identified by mass spectrometry along with the peptide hits, sequence coverage,
Mw and pI values and the increase/decrease of specific carbonyl levels, indexed as fold oxidation.
Protein
Swiss Protein
code
Theorical
Mw/pI
Sequence
Coverage % Score
Fold
oxidation
DYSPLASIA VS. CONTROLS
Keratin, type II
cytoskeletal 6A
Keratin, type II
cytoskeletal 6B
Keratin, type II
cytoskeletal 6C
P02538
P48668
P04259
60293/8.09
60273/8.09
60315/8.09
53
50
49
327
283
311
+9.08
Glyceraldehyde-3-
phosphate
dehydrogenase
P04406 36201/8.57 46 131 +8.62
Cornulin Q9UBG3 53730/5.73 48 229 +4.26
Retinal
Dehydrogenase 1
P00352 55454/6.30 27 125 +31.68
Actin, cytoplasmic 1
Actin, cytoplasmic 2
Q96HG5
P63261
42052/5.29
42108/5.31
79
79
27
27
+9.06
SCC VS. DYSPLASIA
Glyceraldehyde-3-
phosphate
dehydrogenase
P04406 36201/8.57 41 112 210.57
Peptidyl-prolyl cis-
trans isomerase A
P62937 18229/7.68 41 79 2313.34
Erp 57 P30101 57146/5.98 22 96 216.55
Serpin B3 Q8IXI3 44594/6.35 187 37 25.18
Annexin A2 P07355 38808/7.57 45 168 2106.75
doi:10.1371/journal.pone.0034366.t003
Table 4. Expression levels, carbonyl levels and enzyme
activity of GAPDH in controls (CTR), dysplastic (DYS) and
carcinoma tissues (SCC) are reported.
CTR DYS SCC
GAPDH
Expression levels
(fold vs. CTR)
160.1 1.660.3 2.460.2
GAPDH
Carbonylation levels
(fold vs. CTR)
160.3 9.060.4 1.260.3
GAPDH
Enzymatic activity
(uA/mg)
4565.4
(100612%)
26.866.3
(59.5614%)
52.864.9
(117.3611%)
Levels are expressed as fold increase/decrease vs CTR. Enzyme activity is
calculated as A340/mg protein and also as % vs CTR. Data are expressed as mean
6 SEM.
doi:10.1371/journal.pone.0034366.t004
Table 5. 8-OH-dG levels in control (CTR), dysplastic (DYS) and
carcinoma tissues (SCC) are reported as ng of 8-OH-dG/mg
DNA.
8-OH-dG CTR DYS SCC
ng/mg DNA 168614 213618 6068
Data are expressed as mean 6 SEM.
doi:10.1371/journal.pone.0034366.t005
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Interestingly, the increased expression of ERp57 in neoplastic
tissues is also associated with its reduced oxidation possibly
resulting in a much greater increase of activity than expected
based on purely quantitative data. This result underscores the
relevance that elevated protein folding/unfolding activity may
have for cell survival of cancer cells and suggests that the
achievement of the neoplastic phenotype is accompanied by the
activation of compensatory mechanisms able to counteract
oxidative damage of selected targets and allowing the cell to fit
to the hostile environment.
A similar lower level of carbonylation in tumor tissues compared
with dysplastic lesions was also showed for Anx2. Recent studies
suggest that Anx2 might be linked to carcinogenesis through its
implication in the invasion and neovascularisation processes [45]
and that the protein is regulated by the cellular redox status [46].
We have previously reported that Anx2 is oxidized in NHEK and
in HPV-transformed keratinocytes upon exposure to oxidative
stress [16,20]. However, tumour cells once adapted to a more
oxidized environment have improved antioxidant/detoxifying
mechanisms and therefore are able to survive under stress. Thus,
neoplastic cells are paradoxically able to protect themselves from
oxidative damage.
Serpin B3, also known as Squamous Cell Carcinoma Antigen 1,
is a serine protease inhibitor involved in regulation of plasminogen
activation, inhibition of inflammation and promotion of epithelial
proliferation [47]. It binds directly to the HPV16-E7 antigen and
interestingly is overexpressed in tumour cells and correlate with
tumour progression and it is believed to act as a molecular switch
that inhibits cell death [48]. Our results suggest that reduced
oxidation of serpin B3 in tumours might favor tumour cell
proliferation.
Pin1 [named after the acronym: Protein Interacting with NIMA
( = Never In A Mithosis)] is indeed a Peptidyl prolyl cis-trans
isomerase that isomerizes phospho-Serine/Threonine-Proline
[p(S/T)-P] motifs causing them to twist between two completely
distinct conformations. Pin1 is required for cell division, regulates
the cell cycle and, once over-expressed, can promote oncogenesis
through a number of signaling pathways [49]. The finding that
Pin1 is less oxidized in tumor tissue compared with dysplasia may
further correlate with the ability of tumor cells to withstand high
levels of ROS by protecting several cellular component from
oxidative insult.
GAPDH has long been considered a ‘‘simple’’ glycolitic
enzyme and has been widely (and erroneously) used as an
internal standard reference for RNA expression. Indeed GAPDH
is tightly regulated at both transcriptional and post-translational
level [50,51]. In addition to its conventional metabolic role many
other functions have been identified so far implying the
participation of GAPDH to many cell function including cell
adhesion and motility, endocytosis and nuclear membrane
assembly, ER and Golgi trafficking, tRNA export, DNA repair,
telomere protection and cell death [52,53]. We found increased
oxidation of GAPDH in dysplastic lesions vs control tissues while
decreased oxidation was evident in neoplastic tissues vs dysplasia.
The increased oxidation/dysfunction in dysplasia leads to
decreased enzyme activity. Conversely, in neoplastic cells a
reduced levels of oxidation was coupled with a conspicuous
recovery of enzymatic activity.
Figure 6. Proposed scenario of putative interplay between oxidative stress and tumor development. Function of the proteins showing
altered oxidation in both DYS and SCC are listed. DYS is characterized by an increased oxidative environment, compared with both control and SCC
tissues.
doi:10.1371/journal.pone.0034366.g006
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This protection may once again represent a pro-survival
mechanism which makes tumors/adapted cell more resistant to
stress stimuli and therefore able to proliferate [53].
Conclusions
In order to identify putative molecular marker(s) able to
correlate with clinical and biological evolution of cervical
dysplastic lesions, we analyzed the expression of stress response
proteins and the pattern of oxidative adducts on DNA and
proteins in a set of normal, dysplastic and neoplastic cervical
tissues infected with HPV-16 mostly in an integrated status.
The up-regulation of stress protein markers indicated that an
increased oxidative environment occur both in dysplastic and
neoplastic tissues. However, in dysplastic tissues this condition
resulted in oxidative modification of DNA and of proteins involved
in cell morphogenesis and terminal differentiation such as CK6,
actin, cornulin, RDH and GAPDH, providing the conditions for
the neoplastic progression. Conversely cancer tissues seem to gain
an improved control on oxidative damage as shown by the
selective reduction of carbonyl adducts on key detoxifying/pro-
survival proteins such as ERp57, Anx2, Serpin B3, Pin1 and
GAPDH (figure 6).
Further studies are needed to better understand the effects of
protein oxidation on cell transformation and cancer promotion.
The comprehension of these phenomena may also concur to
improve current clinical protocols for screening and for prognostic
evaluation of cervical lesions.
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